T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant - Related Studies

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant

This study is currently recruiting participants.

Study NCT00651716. Last updated on November 13, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Gestational Trophoblastic Tumor
		Leukemia
		Lymphoma
		Myelodysplastic Syndromes
		Neuroblastoma
		Ovarian Cancer
		Testicular Germ Cell Tumor

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Gestational Trophoblastic Neoplasms
		Graft vs Host Disease
		Lymphoma, Large-Cell, Immunoblastic
		Lymphoma, Non-Hodgkin
		Multiple Myeloma
		Myelodysplastic-Myeloproliferative Diseases
		Myeloproliferative Disorders
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Plasma Cell
		Ovarian Neoplasms
		Preleukemia
		Syndrome
		Trophoblastic Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Blood Protein Disorders
		Bone Marrow Diseases
		Breast Diseases
		Cardiovascular Diseases
		Disease
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Hematologic Diseases
		Hemorrhagic Disorders
		Hemostatic Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Neuroectodermal Tumors
		Neuroectodermal Tumors, Primitive
		Neuroectodermal Tumors, Primitive, Peripheral
		Ovarian Diseases
		Paraproteinemias
		Pathologic Processes
		Precancerous Conditions
		Pregnancy Complications
		Pregnancy Complications, Neoplastic
		Skin Diseases
		Urogenital Neoplasms
		Vascular Diseases

4	Interventions listed in this trial
		flow cytometry
		laboratory biomarker analysis
		medical chart review

5	Sponsors listed in this trial
		Vanderbilt-Ingram Cancer Center
		National Cancer Institute (NCI)